139 | ENHANCED CAR T‐CELL EXPANSION AND DURABLE COMPLETE RESPONSES WITH NKTR‐255 PLUS LISOCABTAGENE MARALEUCEL IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMAAlexandre V. Hirayama, Cameron J. Turtle, Aiko Torkelson et al.|Hematological Oncology|2025Cited by 1
Trends in Pre-CAR-T Attrition in Relapsed/Refractory Multiple Myeloma: Prevalence, Risk Factors, and Outcomes at a Tertiary Academic Medical CenterAndrew J. Portuguese, Andrew J. Cowan, Mahnoosh Taheri et al.|Blood|2024Cited by 0
Independent assessment of ALC thresholds currently in use to predict motor/neurocognitive toxicities (MNTs) after treatment with ciltacabtagene autoleucelYein Jeon, Jordan Gauthier, Xiancheng Wu et al.|Blood|2025Cited by 0